138
Views
0
CrossRef citations to date
0
Altmetric
Review

Preventing suicidal behavior in patients with multiple sclerosis: a scoping review

, &
Pages 945-952 | Received 09 Aug 2018, Accepted 15 Nov 2018, Published online: 23 Nov 2018

References

  • Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502–1517.
  • Evans C, Beland SG, Kulaga S, et al. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 2013;40:195–210.
  • Kingwell E, Marriott JJ, Jette N, et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol. 2013;13:128.
  • Federation MSI. Atlas of MS 2013: mapping multiple sclerosis around the world. London, UK: Multiple Sclerosis International Federation; 2013.
  • Bronnum-Hansen H, Koch-Henriksen N, Stenager E. Trends in survival and cause of death in Danish patients with multiple sclerosis. Brain. 2004;127:844–850.
  • Koch-Henriksen N, Laursen B, Stenager E, et al. Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study. J Neurol Neurosurg Psychiatry. 2017;88:626–631.
  • Manouchehrinia A, Tanasescu R, Tench CR, et al. Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios. J Neurol Neurosurg Psychiatry. 2016;87:324–331.
  • Scalfari A, Knappertz V, Cutter G, et al. Mortality in patients with multiple sclerosis. Neurology. 2013;81:184–192.
  • Stenager EN, Stenager E, Koch-Henriksen N, et al. Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg. 1992;55:542–545.
  • Stenager EN, Jensen B, Stenager M, et al. Suicide attempts in multiple sclerosis. Mult Scler. 2011;17:1265–1268.
  • Schotte DE, Clum GA. Problem-solving skills in suicidal psychiatric patients. J Consult Clin Psychol. 1987;55:49.
  • Williams JMG, Pollock LR. Psychological aspects of the suicidal process. In K van Heeringen (ed). Understanding suicidal behaviour. 2001 p. 76–93. John Wiley and Sons.
  • Ajzen I. The theory of planned behavior. Organ Behav Hum Dec. 1991;50:179–211.
  • O’Connor RC. The integrated motivational-volitional model of suicidal behavior. Crisis. 2011;32:295–298.
  • Hassett AL, Aquino JK, Ilgen MA. The risk of suicide mortality in chronic pain patients. Curr Pain Headache Rep. 2014;18:436.
  • Hecimovic H, Salpekar J, Kanner AM, et al. Suicidality and epilepsy: a neuropsychobiological perspective. Epilepsy Behav. 2011;22:77–84.
  • Stenager E, Stenager E. Suicidal behaviour and somatic disorders. Ugeskr Laeger. 2008;170:517–522.
  • Nock MK, Hwang I, Sampson N, et al. Cross-national analysis of the associations among mental disorders and suicidal behavior: findings from the WHO world mental health surveys. PLoS Med. 2009;6:e1000123.
  • Chwastiak LA, Ehde DM. Psychiatric issues in multiple sclerosis. Psychiatr Clin North Am. 2007;30:803–817.
  • Marrie RA, Horwitz R, Cutter G, et al. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler. 2009;15:385–392.
  • Rosti-Otajärvi E, Hämäläinen P. Behavioural symptoms and impairments in multiple sclerosis: a systematic review and meta-analysis. Mult Scler J. 2013;19:31–45.
  • Feinstein A. Multiple sclerosis and depression. Mult Scler. 2011;17:1276–1281.
  • Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry. 2005;76:469–475.
  • Zorzon M, Zivadinov R, Nasuelli D, et al. Depressive symptoms and MRI changes in multiple sclerosis. Eur J Neurol. 2002;9:491–496.
  • Feinstein A, Roy P, Lobaugh N, et al. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology. 2004;62:586–590.
  • Bakshi R, Czarnecki D, Shaikh ZA, et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport. 2000;11:1153–1158.
  • Pujol J, Bello J, Deus J, et al. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology. 1997;49:1105–1110.
  • Berg D, Supprian T, Thomae J, et al. Lesion pattern in patients with multiple sclerosis and depression. Mult Scler. 2000;6:156–162.
  • Krause M, Wendt J, Dressel A, et al. Prefrontal function associated with impaired emotion recognition in patients with multiple sclerosis. Behav Brain Res. 2009;205:280–285.
  • Rocca MA, Pravata E, Valsasina P, et al. Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression. Hum Brain Mapp. 2015;36:5051–5063.
  • Gobbi C, Rocca MA, Pagani E, et al. Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis. Mult Scler. 2014;20:1633–1640.
  • Shen Y, Bai L, Gao Y, et al. Depressive symptoms in multiple sclerosis from an in vivo study with TBSS. Biomed Res Int. 2014;2014:1–8.
  • Passamonti L, Cerasa A, Liguori M, et al. Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis. Brain. 2009;132:3380–3391.
  • Lynch SG, Kroencke DC, Denney DR. The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope. Mult Scler. 2001;7:411–416.
  • Pakenham KI. Adjustment to multiple sclerosis: application of a stress and coping model. Health Psychol. 1999;18:383.
  • Barnwell AM, Kavanagh DJ. Prediction of psychological adjustment to multiple sclerosis. Soc sci med. 1997;45:411–418.
  • Shnek ZM, Foley FW, LaRocca NG, et al. Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Ann Behav Med. 1997;19:287–294.
  • Riazi A, Thompson A, Hobart J. Self-efficacy predicts self-reported health status in multiple sclerosis. Mult Scler J. 2004;10:61–66.
  • Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology. 2002;59:674–678.
  • Johansson S, Gottberg K, Kierkegaard M, et al. Variations in and predictors of the occurrence of depressive symptoms and mood symptoms in multiple sclerosis: a longitudinal two-year study. BMC Neurol. 2016;16:32.
  • Arnett PA, Higginson CI, Voss WD, et al. Relationship between coping, cognitive dysfunction and depression in multiple sclerosis. Clin Neuropsychol. 2002;16:341–355.
  • Rabinowitz AR, Arnett PA. A longitudinal analysis of cognitive dysfunction, coping, and depression in multiple sclerosis. Neuropsychology. 2009;23:581–591.
  • McCabe MP, McKern S, McDonald E. Coping and psychological adjustment among people with multiple sclerosis. J Psychosom Res. 2004;56:355–361.
  • Hakim EA, Bakheit A, Bryant T, et al. The social impact of multiple sclerosis-a study of 305 patients and their relatives. Disabil Rehabil. 2000;22:288–293.
  • Wilski M, Tasiemski T, Kocur P. Demographic, socioeconomic and clinical correlates of self-management in multiple sclerosis. Disabil Rehabil. 2015;37:1970–1975.
  • Catanzaro M, Weinert C. Economic status of families living with multiple sclerosis. Int J Rehabi Res. 1992;15:209–218.
  • Lorefice L, Fenu G, Frau J, et al. The impact of visible and invisible symptoms on employment status, work and social functioning in Multiple Sclerosis. Work (Reading, Mass). 2018;60:263-270.
  • Moore P, Harding KE, Clarkson H, et al. Demographic and clinical factors associated with changes in employment in multiple sclerosis. Mult Scler. 2013;19:1647–1654.
  • Hilt Pfleger CC, Meulengracht Flachs E, Koch-Henriksen N. Social consequences of multiple sclerosis (1): early pension and temporary unemployment—a historical prospective cohort study. Mult Scler J. 2010;16:121–126.
  • Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61:807–816.
  • Mellentin AI, Nielsen B, Stenager E, et al. The effect of co-morbid depression and anxiety on the course and outcome of alcohol outpatient treatment: A naturalistic prospective cohort study. Nord J Psychiatry. 2015;69:331–338.
  • Beier M, D’Orio V, Spat J, et al. Alcohol and substance use in multiple sclerosis. J Neurol Sci. 2014;338:122–127.
  • Bombardier C, Blake K, Ehde D, et al. Alcohol and drug abuse among persons with multiple sclerosis. Mult Scler J. 2004;10:35–40.
  • Nock MK, Hwang I, Sampson NA, et al. Mental disorders, comorbidity and suicidal behavior: results from the national comorbidity survey replication. Mol Psychiatry. 2010;15:868–876.
  • Hoang H. Psychiatric co-morbidity in patients with multiple sclerosis. Denmark: University of Southern Denmark; 2016.
  • Pfleger CC, Flachs EM, Koch-Henriksen N. Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study. Mult Scler. 2010;16:878–882.
  • Pfleger CC, Flachs EM, Koch-Henriksen N. Social consequences of multiple sclerosis: clinical and demographic predictors - a historical prospective cohort study. Eur J Neurol. 2010;17:1346–1351.
  • Dalton EJ, Heinrichs RW. Depression in multiple sclerosis: a quantitative review of the evidence. Neuropsychology. 2005;19:152–158.
  • Hesdorffer DC. Comorbidity between neurological illness and psychiatric disorders. CNS Spectr. 2016;21:230–238.
  • Viner R, Patten SB, Berzins S, et al. Prevalence and risk factors for suicidal ideation in a multiple sclerosis population. J Psychosom Res. 2014;76:312–316.
  • Hung Y, Yarmak P. Neurorehabilitation for multiple sclerosis patients with emotional dysfunctions. Front Neurol. 2015;6:272.
  • Mohr DC, Hart SL, Julian L, et al. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. Bmj. 2004;328:731.
  • Briones-Buixassa L, Mila R, MfA J, et al. Stress and multiple sclerosis: A systematic review considering potential moderating and mediating factors and methods of assessing stress. Health Psychol Open. 2015;2:2055102915612271.
  • Bolton JM, Gunnell D, Turecki G. Suicide risk assessment and intervention in people with mental illness. BMJ. 2015;351:h4978.
  • Klonsky ED, May AM, Saffer BY. Suicide, suicide attempts, and suicidal ideation. Annu Rev Clin Psychol. 2016;12:307–330.
  • Feinstein A, Magalhaes S, Richard J-F, et al. The link between multiple sclerosis and depression. Nat Rev Neurol. 2014;10:507.
  • Beck AT, Steer RA. Internal consistencies of the original and revised beck depression inventory. J Clin Psychol. 1984;40:1365–1367.
  • Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol. 1979;47:343.
  • Beck AT, Weissman A, Lester D, et al. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol. 1974;42:861.
  • Beck AT, Steer RA, Carbin MG. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77–100.
  • Beck AT, Steer RA, Brown GK. Beck depression inventory-II. San Antonio. 1996;78:490–498.
  • Beck AT, Schuyler D, Herman I. Development of suicidal intent scales. Philadelphia: Charles Press Publishers; 1974.
  • Patterson WM, Dohn HH, Bird J, et al. Evaluation of suicidal patients: the SAD PERSONS scale. Psychosomatics. 1983;24:343–345.
  • Posner K, Brent D, Lucas C, et al. Columbia-suicide severity rating scale (C-SSRS). New York, NY: Columbia University Medical Center; 2008.
  • Yaseen Z, Katz C, Johnson MS, et al. Construct development: the suicide trigger scale (STS-2), a measure of a hypothesized suicide trigger state. BMC Psychiatry. 2010;10:110.
  • Yaseen ZS, Gilmer E, Modi J, et al. Emergency room validation of the revised suicide trigger scale (STS-3): a measure of a hypothesized suicide trigger state. PloS one. 2012;7:e45157.
  • Cull JG, Gill WS. Suicide probability scale (SPS). Los Angeles: Western Psychological Services; 1989.
  • Nock MK, Holmberg EB, Photos VI, et al. Self-injurious thoughts and behaviors interview: development, reliability, and validity in an adolescent sample. Psychological assessments. 2007;19:309-317.
  • Weitz E, Hollon SD, Kerkhof A, et al. Do depression treatments reduce suicidal ideation? The effects of CBT, IPT, pharmacotherapy, and placebo on suicidality. J Affect Disord. 2014;167:98–103.
  • Pérez LP, González RS, Lázaro EB. Treatment of mood disorders in multiple sclerosis. Curr Treat Options Neurol. 2015;17:323.
  • Koch MW, Glazenborg A, Uyttenboogaart M, et al. Pharmacologic treatment of depression in multiple sclerosis. In: The cochrane database of systematic reviews. 2011;2:CD007295.
  • Yahno NN, Fedotova AV. Post-marketing observational program of the effectiveness of fluvoxamine for the treatment of depression in patients with neurological disorders: the FRIENDS study. Neuropsychiatr Dis Treat. 2017;13:2747–2756.
  • Brown GK, Green KL. A review of evidence-based follow-up care for suicide prevention: where do we go from here? Am J Prev Med. 2014;47:S209–S15.
  • Rosti-Otajarvi EM, Hamalainen PI. Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev. 2014;2:CD009131.
  • Hind D, Cotter J, Thake A, et al. Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis. BMC Psychiatry. 2014;14:5.
  • Simpson R, Booth J, Lawrence M, et al. Mindfulness based interventions in multiple sclerosis–a systematic review. BMC Neurol. 2014;14:15.
  • Sheppard SC, Forsyth JP, Hickling EJ, et al. A novel application of acceptance and commitment therapy for psychosocial problems associated with multiple sclerosis: results from a half-day workshop intervention. Int J MS Care. 2010;12:200–206.
  • Graham CD, Gouick J, Krahé C, et al. A systematic review of the use of acceptance and commitment therapy (ACT) in chronic disease and long-term conditions. Clin Psychol Rev. 2016;46:46–58.
  • Pakenham KI, Scott T, Uccelli MM. Short report: evaluation of acceptance and commitment therapy training for psychologists working with people with multiple sclerosis. Int J MS Care. 2018;20:44–48.
  • Eisenberger NI. An empirical review of the neural underpinnings of receiving and giving social support: implications for health. Psychosom Med. 2013;75:545.
  • Costa DC, Sá MJ, Calheiros JM. The effect of social support on the quality of life of patients with multiple sclerosis. Arq Neuropsiquiatr. 2012;70:108–113.
  • Krokavcova M, van Dijk JP, Nagyova I, et al. Social support as a predictor of perceived health status in patients with multiple sclerosis. Patient Educ Couns. 2008;73:159–165.
  • Bombardier CH, Wadhwani R, LaRotonda C. Health promotion in people with multiple sclerosis. Phys Med Rehabil Clin N Am. 2005;16:557–570.
  • Campbell TL. The effectiveness of family interventions for physical disorders. J Marital Fam Ther. 2003;29:263–281.
  • Vassilev I, Rogers A, Sanders C, et al. Social networks, social capital and chronic illness self-management: a realist review. Chronic Illn. 2011;7:60–86.
  • Meis LA, Griffin JM, Greer N, et al. Couple and family involvement in adult mental health treatment: a systematic review. Clin Psychol Rev. 2013;33:275–286.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.